Spots Global Cancer Trial Database for Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Official Title: Radium-223 Chloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Study ID: NCT01516762
Conditions
Interventions
Study Description
Brief Summary: This study is a prospective, interventional, open-label, multi-center early access program for the use of Ra-223 Cl2 in HRPC/CRPC patients diagnosed with symptomatic bone metastasis and to collect additional short and long term safety data on the product.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
, Birmingham, Alabama, United States
, Phoenix, Arizona, United States
, Scottsdale, Arizona, United States
, Greenbrae, California, United States
, La Jolla, California, United States
, San Francisco, California, United States
, Stanford, California, United States
, Aurora, Colorado, United States
, Newark, Delaware, United States
, Washington, District of Columbia, United States
, Washington, District of Columbia, United States
, Fort Myers, Florida, United States
, Miami Beach, Florida, United States
, Tampa, Florida, United States
, Atlanta, Georgia, United States
, Honolulu, Hawaii, United States
, Goshen, Indiana, United States
, Iowa City, Iowa, United States
, New Orleans, Louisiana, United States
, Shreveport, Louisiana, United States
, Baltimore, Maryland, United States
, Baltimore, Maryland, United States
, Baltimore, Maryland, United States
, Bethesda, Maryland, United States
, Rockville, Maryland, United States
, Boston, Massachusetts, United States
, Boston, Massachusetts, United States
, Ann Arbor, Michigan, United States
, Detroit, Michigan, United States
, Detroit, Michigan, United States
, Minneapolis, Minnesota, United States
, St. Louis, Missouri, United States
, Las Vegas, Nevada, United States
, New Brunswick, New Jersey, United States
, Newark, New Jersey, United States
, New Hyde Park, New York, United States
, New York, New York, United States
, New York, New York, United States
, Syracuse, New York, United States
, Durham, North Carolina, United States
, Raleigh, North Carolina, United States
, Cleveland, Ohio, United States
, Columbus, Ohio, United States
, Springfield, Oregon, United States
, Philadelphia, Pennsylvania, United States
, Philadelphia, Pennsylvania, United States
, Philadelphia, Pennsylvania, United States
, Pittsburgh, Pennsylvania, United States
, Myrtle Beach, South Carolina, United States
, Myrtle Beach, South Carolina, United States
, Nashville, Tennessee, United States
, Houston, Texas, United States
, Plano, Texas, United States
, San Antonio, Texas, United States
, Temple, Texas, United States
, Hampton, Virginia, United States
, Norfolk, Virginia, United States
, Seattle, Washington, United States
, Wheeling, West Virginia, United States
, Milwaukee, Wisconsin, United States
Contact Details
Name: Bayer Study Director
Affiliation: Bayer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
